TESTING FOR BIMODALITY IN FREQUENCY-DISTRIBUTIONS OF DATA SUGGESTING POLYMORPHISMS OF DRUG-METABOLISM - HISTOGRAMS AND PROBIT PLOTS

被引:38
作者
JACKSON, PR
TUCKER, GT
WOODS, HF
机构
关键词
D O I
10.1111/j.1365-2125.1989.tb03557.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:647 / 653
页数:7
相关论文
共 19 条
[11]   PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN [J].
KUPFER, A ;
PREISIG, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :753-759
[12]   DEBRISOQUINE POLYMORPHISM AND THE METABOLISM AND ACTION OF METOPROLOL, TIMOLOL, PROPRANOLOL AND ATENOLOL [J].
LENNARD, MS ;
TUCKER, GT ;
SILAS, JH ;
WOODS, HF .
XENOBIOTICA, 1986, 16 (05) :435-447
[13]  
MACLEAN CJ, 1976, BIOMETRICS, V32, P365
[14]   POLYMORPHISM OF THEOPHYLLINE METABOLISM IN MAN [J].
MILLER, CA ;
SLUSHER, LB ;
VESELL, ES .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (05) :1415-1425
[15]   ONE CAUSE . MANY CAUSES - ARGUMENT FROM BIMODAL DISTRIBUTION [J].
MURPHY, EA .
JOURNAL OF CHRONIC DISEASES, 1964, 17 (04) :301-&
[16]   INTERETHNIC DIFFERENCES IN GENETIC-POLYMORPHISM OF DEBRISOQUIN AND MEPHENYTOIN HYDROXYLATION BETWEEN JAPANESE AND CAUCASIAN POPULATIONS [J].
NAKAMURA, K ;
GOTO, F ;
RAY, WA ;
MCALLISTER, CB ;
JACQZ, E ;
WILKINSON, GR ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :402-408
[17]   MONOGENIC CONTROL OF VARIATIONS IN ANTIPYRINE METABOLITE FORMATION - NEW POLYMORPHISM OF HEPATIC DRUG OXIDATION [J].
PENNO, MB ;
VESELL, ES .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06) :1698-1709
[18]  
PRICEEVANS DA, 1980, J MED GENET, V17, P102
[19]  
SUZUKI DT, 1981, INTRO GENETIC ANAL